Mustang Bio (MBIO) Total Debt (2016 - 2023)
Mustang Bio (MBIO) posted quarterly Total Debt of $28.2 million for Q1 2023, up 1.38% year-over-year from $27.8 million in Q1 2022, and little changed quarter-over-quarter from $28.2 million in Q4 2022.
Mustang Bio (MBIO) Total Debt (2016 - 2023) Analysis & Trends
Mustang Bio (MBIO) has reported Total Debt for 6 consecutive years, with $28.2 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Total Debt rose 1.38% year-over-year to $28.2 million; the TTM figure through Mar 2023 stood at $28.2 million (up 1.38% YoY), while the FY2022 annual figure was $28.2 million, up 3800.69% from the prior year.
- Total Debt steadied at $28.2 million in Q1 2023 per MBIO's latest filing, from $28.2 million in the prior quarter.
- Across five years, Total Debt topped out at $28.2 million in Q4 2022 and bottomed at $249000.0 in Q2 2021.
- Historically, Total Debt has averaged $13.4 million across 5 years, with a median of $12.8 million in 2019.
- Annual changes were most pronounced in 2021 — Total Debt sank 97.37% — and 2022, when it surged 10983.53%.
- Mustang Bio's Total Debt stood at $13.4 million in 2019, then tumbled by 96.35% to $490000.0 in 2020, then soared by 47.55% to $723000.0 in 2021, then soared by 3800.69% to $28.2 million in 2022, then retreated by 0.08% to $28.2 million in 2023.
- Business Quant data shows MBIO's Total Debt at $28.2 million in Q1 2023, $28.2 million in Q4 2022, and $27.4 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 28.18 Mn |
| Dec 31, 2022 | 28.20 Mn |
| Sep 30, 2022 | 27.45 Mn |
| Jun 30, 2022 | 27.60 Mn |
| Mar 31, 2022 | 27.80 Mn |
| Dec 31, 2021 | 723,000.00 |
| Sep 30, 2021 | 296,000.00 |
| Jun 30, 2021 | 249,000.00 |
| Mar 31, 2021 | 343,000.00 |
| Dec 31, 2020 | 490,000.00 |
| Jun 30, 2020 | 9.45 Mn |
| Mar 31, 2020 | 11.11 Mn |
| Dec 31, 2019 | 13.43 Mn |
| Sep 30, 2019 | 13.47 Mn |
| Jun 30, 2019 | 12.95 Mn |
| Mar 31, 2019 | 12.73 Mn |
| Sep 30, 2016 | 2.93 Mn |